medic
veterinari
diagnost
public
health
laboratori
worldwid
increasingli
call
upon
introduc
molecular
diagnost
test
endem
exot
diseas
demand
acceler
follow
increas
terror
fear
iron
concern
lead
tighten
import
export
control
prevent
mani
laboratori
particularli
outsid
unit
state
gain
access
posit
control
materi
turn
prevent
mani
laboratori
introduc
much
need
molecular
diagnost
test
describ
gener
approach
prepar
synthet
dna
rna
control
materi
use
either
taqman
convent
pcr
assay
product
synthet
control
use
approach
requir
clone
special
equip
facil
beyond
found
laboratori
perform
molecular
diagnost
approach
significantli
reduc
possibl
contamin
erron
report
falseposit
reaction
due
contamin
posit
control
materi
synthet
control
produc
use
approach
employ
molecular
diagnost
test
perform
laboratori
use
irrespect
whether
possess
organ
public
health
laboratori
worldwid
expect
extens
repertoir
test
avail
rapid
diagnosi
endem
exot
viral
diseas
frank
rotz
et
al
rotz
et
al
readi
access
scientif
journal
allow
rapid
introduct
molecular
assay
wide
rang
exot
virus
access
genom
databas
via
internet
enabl
develop
inhous
molecular
assay
varieti
format
wide
array
pathogen
biggest
stumbl
block
laboratori
introduc
assay
lack
appropri
posit
control
materi
iron
increas
concern
terror
heighten
demand
broadli
expand
diagnost
capabl
also
correspond
author
tel
fax
email
address
greg
smith
healthqldgovau
g
smith
increas
restrict
import
export
exot
virus
even
extract
genet
materi
use
control
assay
australia
laboratori
face
dual
obstacl
identifi
countri
prepar
releas
materi
plu
difficulti
convinc
australian
quarantin
author
approv
import
materi
diagnost
purpos
molecular
diagnost
cornerston
routin
viral
diagnosi
mani
clinic
public
health
laboratori
problem
falseposit
result
due
cross
contamin
molecular
diagnost
laboratori
well
known
well
document
aslanzadeh
borst
et
al
landri
tele
et
al
problem
falseposit
result
greatli
reduc
provid
test
conduct
appropri
design
facil
dedic
room
reagent
prepar
nucleic
acid
extract
amplif
post
pcr
analysi
provid
strict
enforc
direct
movement
peopl
materi
observ
borst
al
millar
et
al
even
dedic
room
direct
movement
employ
falseposit
still
occur
borst
et
al
circumst
sourc
contamin
often
link
extract
posit
sampl
room
time
sinc
posit
control
includ
everi
extract
procedur
often
repres
common
sourc
contamin
nucleic
acid
intact
viru
extract
viral
nucleic
acid
clone
unmodifi
viral
segment
repres
potenti
sourc
contamin
nucleic
acid
employ
posit
control
addit
use
live
viru
routin
sourc
posit
control
materi
also
present
signific
unnecessari
occup
health
safeti
concern
laboratori
requir
posit
control
may
even
preclud
laboratori
perform
molecular
diagnost
test
pathogen
proper
contain
facil
handl
instanc
australia
sar
coronaviru
prepar
viral
rna
control
handl
facil
clinic
materi
submit
sar
exclus
test
use
molecular
detect
handl
contain
condit
provid
addit
precaut
follow
describ
two
approach
prepar
synthet
posit
control
materi
molecular
detect
virtual
viru
irrespect
whether
test
publish
method
develop
inhous
base
publish
sequenc
inform
either
method
use
rna
dna
virus
suitabl
adopt
laboratori
capabl
perform
pcr
method
use
routin
laboratori
molecular
assay
irrespect
whether
hold
viru
collect
first
method
applic
realtim
pcr
taqman
assay
second
method
suitabl
convent
singl
round
nest
pcr
method
use
establish
control
assay
varieti
viral
diseas
exot
australia
could
introduc
countri
via
intern
air
travel
intent
releas
inhous
develop
taqman
assay
revers
transcriptas
rt
pcr
test
base
publish
method
sar
coronaviru
drosten
et
al
use
illustr
purpos
describ
construct
control
test
paper
intend
present
gener
approach
product
synthet
control
describ
detail
molecular
diagnost
test
sar
mani
alreadi
describ
compar
mahoni
et
al
drosten
et
al
sar
coronaviru
use
studi
gener
provid
professor
jsm
peri
depart
microbiolog
univers
hong
kong
propag
passag
contain
condit
c
vero
cell
atcc
optimem
contain
fetal
bovin
serum
antibiot
sar
genom
rna
provid
part
nation
qc
panel
dr
mike
catton
victorian
infecti
diseas
refer
laboratori
melbourn
australia
plasmid
use
studi
purchas
new
england
biolab
usa
two
separ
synthet
control
oligonucleotid
routin
employ
laboratori
detect
viral
pathogen
taqman
case
sar
first
probe
control
nucleotid
long
doubl
strand
consist
sar
coronaviru
taqman
probe
sequenc
bold
flank
rodent
dehydrogenas
rgapdh
forward
revers
primer
sequenc
ital
describ
rgapdh
taqman
assay
perkinelm
fig
bacteriophag
fig
schemat
show
creation
pcr
amplicon
subsequ
use
templat
gener
synthet
rna
control
use
first
round
rtpcr
reaction
rna
polymeras
bind
site
underlin
includ
end
oligonucleotid
allow
rna
transcript
oligonucleotid
addit
four
nucleotid
includ
extrem
end
oligonucleotid
target
inhous
develop
sar
coronaviru
taqman
highli
stabl
region
probe
control
consist
aaaa
promot
rgapdh
forward
sar
probe
rgapdh
revers
actual
nucleotid
sequenc
posit
sens
probe
control
aaaataatacgactcactatagggtgcaccaccaactgcttag
cgttcgtgcgtggat
rel
nucleotid
posit
base
full
genom
length
sequenc
sar
coronaviru
genbank
access
second
hplc
purifi
oligonucleotid
design
complimentari
strand
describ
also
obtain
two
separ
oligonucleotid
dilut
concentr
anneal
first
heat
c
min
allow
cool
room
temperatur
doubl
strand
oligonucleotid
use
produc
rna
control
materi
describ
second
control
primer
control
construct
similar
manner
gapdh
probe
sequenc
bold
replac
sar
probe
sequenc
sar
forward
revers
primer
sequenc
ital
substitut
gapdh
primer
sequenc
fig
first
round
primer
pair
chosen
use
primer
design
softwar
primer
express
tm
version
perkinelm
appli
biosystem
usa
produc
product
approxim
bp
length
dna
product
bp
larger
expect
first
round
product
bp
first
round
primer
design
smai
contain
multipl
clone
site
plasmid
would
locat
approxim
middl
result
amplicon
allow
later
digest
product
smai
digest
fig
primer
design
incorpor
addit
first
round
forward
primer
sequenc
sar
coronaviru
atgaattacc
aagtcaatggttac
end
specif
sequenc
end
first
round
control
forward
primer
extend
inclus
rna
polymeras
promot
sequenc
four
addit
residu
end
forward
control
primer
order
aaaa
rna
polymeras
sar
fwd
primer
fwd
sequenc
produc
primer
bp
length
sar
coronaviru
control
first
round
revers
primer
sequenc
cataaccagtcggtacagctac
ad
end
specif
sequenc
order
sar
rev
primer
rev
sequenc
produc
primer
bp
length
second
round
control
primer
pair
design
yield
product
approxim
bp
length
bp
larger
expect
second
round
product
size
bp
fig
schemat
oligonucleotid
procedur
produc
synthet
probe
primer
control
use
rttaqman
assay
span
plasmid
multipl
clone
site
second
round
control
forward
primer
base
length
consist
sar
coronaviru
forward
primer
gaagctattcgtcacgttcg
join
specif
sequenc
contrast
first
round
control
forward
primer
rna
polymeras
bind
site
includ
second
round
control
revers
primer
bp
length
compris
sar
coronaviru
revers
primer
ctgtagaaa
atcctagctggag
link
specif
sequenc
standard
amplitaq
gold
hot
start
pcr
cycl
reaction
employ
consist
singl
activ
cycl
c
min
follow
cycl
c
c
min
c
min
follow
singl
extens
cycl
c
min
volum
pcr
mixtur
l
pcr
mixtur
contain
primer
mm
deoxyribonucleosid
triphosph
mm
trishcl
ph
mm
kcl
mm
mgcl
u
amplitaq
gold
dna
polymeras
perkinelm
cetu
ng
undigest
circular
dna
product
analys
electrophoresi
agaros
gel
vcm
band
excis
recov
use
qiagen
gel
purif
kit
qiagen
accord
manufactur
instruct
recov
bp
first
round
pcr
product
use
synthesi
rna
describ
promega
riboprob
kit
use
accord
manufactur
promega
usa
instruct
produc
rna
transcript
either
oligonucleotid
dna
pcr
amplifi
product
follow
dnase
digest
rna
synthesi
reaction
phenol
chloroform
extract
ethanol
precipit
precipit
rna
resuspend
rna
secur
buffer
ambion
usa
analys
presenc
residu
plasmid
dna
oligonucleotid
dna
dilut
sampl
serial
seri
perform
either
pcr
taqman
assay
parallel
without
revers
transcriptas
dilut
use
control
dilut
produc
distinct
product
rt
fail
rt
left
reaction
mix
amplif
detect
sar
rna
synthet
control
materi
perform
abi
prism
sequenc
detector
system
use
singletub
one
step
rttaqman
approach
l
reaction
mix
contain
perkinelm
appli
biosystem
usa
taqman
buffer
mm
kcl
mm
trishcl
mm
edta
nm
rox
passiv
refer
ph
mm
mgcl
dntp
datp
dctp
dgtp
dutp
nm
fam
label
taqman
probe
nm
primer
u
multiscrib
revers
transcriptas
u
rnase
inhibitor
u
taq
gold
polymeras
cycl
consist
one
cycl
c
min
revers
transcript
rna
cdna
follow
one
cycl
c
min
inactiv
revers
transcriptas
cdna
amplifi
cycl
cycl
c
c
min
threshold
cycl
c
determin
neg
result
consid
amplif
occur
reaction
c
equal
greater
cycl
cycl
condit
touchdown
nest
rtpcr
detect
sar
coronaviru
perform
describ
previous
drosten
et
al
superscript
one
step
rtpcr
system
roch
employ
first
round
amplif
primer
pair
first
round
reaction
bniouta
amplif
perform
perkinelm
appli
biosystem
thermocycl
use
l
reaction
compris
rtpcr
reaction
buffer
contain
mm
mgcl
dntp
mm
dtt
u
rnasin
primer
l
titan
enzym
mix
roch
cycl
condit
recommend
includ
initi
revers
transcriptas
cycl
heat
c
min
follow
inactiv
c
min
follow
cycl
denatur
c
anneal
c
anneal
temperatur
decreas
c
per
cycl
cycl
extens
c
follow
cycl
consist
denatur
c
anneal
c
extens
c
pcr
product
first
round
reaction
dilut
steril
water
l
ad
l
second
round
pcr
reaction
consist
pcr
buffer
ii
mm
trishcl
ph
mm
kcl
appli
biosystem
mm
mgcl
dntp
second
round
primer
u
amplitaq
gold
pe
appli
biosystem
two
second
round
primer
bniin
bniina
follow
initi
denatur
c
min
reaction
submit
cycl
c
c
anneal
temperatur
decreas
c
per
cycl
cycl
c
follow
cycl
consist
c
c
c
identifi
amplifi
synthet
control
materi
authent
viral
amplicon
pcr
product
digest
l
reaction
consist
l
pcr
product
l
smai
ul
roch
germani
reaction
incub
c
h
l
gel
load
buffer
promega
ad
reaction
analys
electrophoret
separ
sar
agaros
gel
vcm
synthet
rna
probe
primer
control
produc
typic
amplif
plot
across
rang
serial
dilut
tabl
typic
c
valu
obtain
taqman
reaction
perform
serial
dilut
synthet
probe
control
column
without
column
revers
transcriptas
reaction
tabl
shape
amplif
plot
obtain
synthet
probe
primer
control
virtual
indistinguish
obtain
sar
coronaviru
rna
plot
shown
indic
tabl
residu
dna
templat
present
taqman
control
evidenc
posit
signal
dilut
c
lower
rt
control
column
first
round
synthet
rna
control
produc
posit
easili
discern
band
approxim
bp
length
rtpcr
fig
lane
second
round
dna
control
produc
product
estim
size
approxim
bp
fig
lane
amplicon
discern
larger
bp
product
produc
sar
rna
first
round
fig
lane
second
round
reaction
bp
fig
lane
smai
digest
result
cleavag
synthet
control
first
fig
lane
second
round
product
fig
lane
contrast
smai
fail
cleav
either
first
second
round
rtpcr
product
sar
coronaviru
rna
fig
lane
fig
rtpcr
amplif
product
lane
bp
ladder
bp
band
mark
lane
sar
rna
first
round
product
lane
sar
first
round
product
follow
smai
digest
lane
synthet
rna
control
first
round
product
lane
first
round
synthet
control
follow
smai
digest
lane
sar
rna
second
round
product
lane
sar
second
round
product
follow
smai
digest
lane
synthet
control
second
round
product
lane
synthet
control
second
round
product
follow
smai
digest
lane
templat
control
lane
neg
extract
control
taqman
assay
describ
perform
equal
well
synthet
control
materi
extract
viral
rna
tabl
assay
show
cross
reactiv
respiratori
virus
includ
influenza
influenza
b
respiratori
syncyti
viru
adenoviru
parainfluenza
viru
data
shown
sar
rna
produc
product
predict
size
first
fig
lane
second
round
fig
lane
rtpcr
reaction
use
fulli
synthes
oligonucleotid
pcr
gener
dna
templat
posit
control
materi
right
dna
virus
templat
gener
singlestrand
rna
control
rna
virus
approach
access
laboratori
perform
inhous
gener
pcr
test
approach
requir
clone
product
gener
genet
modifi
organ
specialis
contain
facil
specialis
skill
knowledg
approach
allow
develop
taqman
convent
pcr
assay
virtual
viru
organ
publish
method
sequenc
inform
exist
two
approach
describ
inhous
design
taqman
test
nest
rtpcr
test
base
publish
method
drosten
et
al
allow
us
introduc
molecular
test
sar
soon
sequenc
inform
becam
avail
internet
believ
approach
particularli
use
laboratori
lack
appropri
physic
contain
facil
propag
particular
viru
difficulti
gain
access
organ
question
due
intern
tighten
import
export
control
laboratori
current
perform
larg
number
taqman
convent
pcr
test
broad
rang
endem
exot
viral
diseas
actual
viral
stock
despit
use
synthet
control
produc
describ
assay
order
reduc
risk
falseposit
reaction
use
rna
polymeras
commerci
avail
rna
transcript
kit
possibl
produc
control
monitor
perform
either
rttaqman
rtpcr
detect
rna
virus
stage
reaction
includ
revers
transcript
primer
probe
bind
taq
dna
polymeras
extens
step
small
size
synthet
taqman
dna
templat
residu
dna
frequent
present
follow
mani
commerci
kitbas
rna
transcript
reaction
although
necessari
rna
prepar
total
free
dna
templat
import
dilut
chosen
rt
control
produc
product
follow
pcr
reaction
contain
rt
simpl
dilut
seri
similar
depict
tabl
allow
select
dilut
free
dna
templat
thu
suitabl
use
rt
control
use
synthet
control
taqman
assay
allow
step
reaction
control
includ
revers
transcript
taq
dna
polymeras
activ
primer
fluoresc
probe
use
also
effect
elimin
risk
contamin
either
posit
control
result
amplicon
sinc
neither
probe
primer
control
lead
falseposit
reaction
neither
rgapdh
probe
rgapdh
primer
present
viral
taqman
reaction
mix
use
approach
produc
rna
control
materi
use
rtpcr
taqman
assay
also
import
note
doubl
strand
templat
requir
effect
rna
transcript
rna
polymeras
approach
requir
two
separ
control
reaction
primer
control
probe
control
set
diagnost
assay
inconveni
easili
offset
abil
ensur
compon
assay
work
also
ensur
possibl
produc
falseposit
reaction
due
contamin
either
control
falseneg
reaction
due
inhibitor
efficaci
extract
process
control
whatev
strategi
particular
laboratori
find
appropri
purpos
product
synthet
rtpcr
control
base
similar
plasmid
requir
cloningth
dna
commerci
avail
need
although
approach
potenti
produc
falseposit
product
appropri
size
easi
rule
inadvert
amplif
synthet
control
restrict
endonucleas
digest
use
plasmid
templat
smai
bamhi
contain
multipl
clone
site
product
digest
directli
pcr
buffer
without
buffer
exchang
either
enzym
visualis
electrophoresi
thu
allow
confirm
posit
result
within
h
digest
product
produc
band
expect
size
provid
rapid
confirm
falseposit
reaction
cours
provid
target
organ
possess
smai
bamhi
restrict
endonucleas
recognit
site
nearli
ident
locat
synthet
control
simpl
silico
analysi
target
sequenc
would
allow
unlik
eventu
rule
failur
smai
bamhi
cleav
product
may
warrant
sequenc
confirm
product
posit
report
releas
depend
upon
clinic
public
health
implic
addit
safeguard
employ
design
synthet
control
slightli
smaller
larger
expect
product
thu
allow
immedi
visual
identif
falseposit
due
contamin
synthet
control
contrast
rtpcr
synthet
control
describ
would
much
difficult
even
imposs
distinguish
contamin
clone
viral
materi
laboratori
use
posit
control
real
viru
nucleotid
sequenc
amplifi
contamin
would
indistinguish
actual
viru
although
synthet
control
use
laboratori
wide
varieti
inhous
develop
assay
care
use
approach
fulli
valid
assay
smith
et
al
warrilow
et
al
base
assay
publish
paper
respect
research
group
contain
detail
procedur
perform
assay
laboratori
would
comfort
issu
neg
detect
result
exot
agent
potenti
far
reach
public
health
polit
implic
without
assur
compon
reaction
perform
expect
synthet
control
produc
describ
could
help
address
need
